SCHEMBL7515524

SCHEMBL7515524

O=C1C=C(C=Cc2ccc(C(F)(F)F)cc2)CO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.47
CYP1A2 P05177 2/20 0.45
PTGS1 P23219 3/20 0.44
PTGS2 P35354 2/20 0.43
NR1H3 Q13133 1/20 0.43
FBP1 P09467 1/20 0.42
NQO2 P16083 1/20 0.42
HDAC3 O15379 1/20 0.41
ADAM17 P78536 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519323 1.00 AHR (0.47) AHRCYP1A2PTGS1PTGS2NR1H3
SCHEMBL7515514 1.00 AHR (0.47) AHRCYP1A2PTGS1PTGS2NR1H3
SCHEMBL7518829 0.80 PTGS1 (0.39) PTGS1PTGS2PIM1PIM2
SCHEMBL7518821 0.80 PTGS1 (0.39) PTGS1PTGS2PIM1PIM2
SCHEMBL7520340 0.80 MAOB (0.46) AHRCYP1A2FBP1NFE2L2
SCHEMBL7520343 0.80 MAOB (0.46) AHRCYP1A2FBP1NFE2L2
SCHEMBL7523379 0.80 MAOB (0.42) CYP1A2HIF1ANFE2L2
SCHEMBL7523377 0.80 MAOB (0.42) CYP1A2HIF1ANFE2L2
SCHEMBL7520866 0.77 AHR (0.35) AHRHDAC1HDAC8HDAC6
SCHEMBL7513779 0.77 AHR (0.35) AHRHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed